Unlocking the Secrets to Preventing Strokes: A Medical Breakthrough in the Making
The medical world is on the brink of a potential paradigm shift in treating carotid artery disease, a condition affecting millions, but the journey is filled with controversy and unanswered questions.
Q: Let's dive into this intriguing topic with Dr. Carlos Mena, a renowned professor of cardiovascular medicine. Dr. Mena, you're at the forefront of the CREST-2 clinical trial, a massive international effort. What inspired you to take on this role?
A: Carotid artery disease, where fatty deposits or plaque buildup narrow the arteries, is a significant concern for older adults, with over 3% diagnosed in the US alone. The disease is a major stroke risk factor, and for years, the medical community has debated the best treatment approach, especially for asymptomatic patients. The CREST-2 trial aims to settle this debate by comparing various stroke prevention methods, which is why I was drawn to it.
Q: CREST-2 is a groundbreaking study, but enrolling participants must have been challenging. How did Yale, one of the top enrollers, manage this?
A: Enrolling patients was indeed a hurdle. Many individuals with carotid artery disease are asymptomatic and hesitant to undergo invasive procedures like carotid artery stenting or endarterectomy. Conversely, some patients strongly prefer these procedures over medical management alone. Our success at Yale was a team effort. We ensured every team member understood the trial's significance and took the time to thoroughly explain the process to patients, address their concerns, and schedule follow-ups. I'm incredibly grateful to the Yale Vascular Surgery team and my colleagues, including Shannon Lynch, Amanda Pappas, and Dawn Shaddinger, for their dedication.
Q: The trial's initial results are in. What have we learned about treating carotid artery disease?
A: The New England Journal of Medicine recently published groundbreaking findings. We now have clear evidence that contemporary medical therapy significantly reduces the risk of stroke. Moreover, when performed by an experienced professional, revascularization procedures combined with medical therapy can further lower this risk. These results are a game-changer for stroke prevention and carotid artery disease treatment.
Q: What mysteries remain unsolved, and how might your work contribute to solving them?
A: While we now know that treatment can reduce stroke risk, we're left with a crucial question: should we increase screening for carotid artery disease? The research is not conclusive yet. Additionally, I'm involved in CREST-H, a subgroup of CREST-2, which explores whether stent placements or endarterectomies can improve cognitive function in patients with vascular cognitive impairment due to carotid artery disease. This is a critical aspect of patient care, and our research may provide valuable insights.
But here's where it gets controversial: Should we prioritize invasive procedures for asymptomatic patients to prevent potential future strokes, or is it an unnecessary risk? The medical community's opinions may vary, and we'd love to hear your thoughts in the comments.
And this is the part most people miss: The Yale Department of Internal Medicine's Cardiovascular Medicine section is dedicated to advancing research, educating future cardiologists, and providing exceptional patient care. To learn more about their mission and the team, visit their website.
Disclaimer: This research was supported by various grants and institutions, including the National Institute of Neurological Disorders and Stroke, the National Institutes of Health, the Centers for Medicare and Medicaid Services, and the Department of Health and Human Services. The content reflects the authors' views and not necessarily those of the funding bodies.
Key Contributors:
- Dr. Carlos Mena-Hurtado, a leading expert in cardiovascular medicine.
- Shannon Lynch, FNP, a dedicated staff affiliate.
- Amanda Pappas and Dawn Shaddinger, RN, who played vital roles in patient enrollment and care.
- Dr. Eric Velazquez and Dr. Alexandra Lansky, esteemed professors of cardiology.
Explore More:
- Yale Department of Internal Medicine Website
- Dr. Carlos Mena-Hurtado's Profile
- Shannon Lynch's Profile
- Amanda Pappas's Profile
- Dawn Shaddinger's Profile
- Dr. Eric Velazquez's Profile
- Dr. Alexandra Lansky's Profile
Tags:
- Clinical Research
- Cardiology and Vascular
- Alumni
- Cardiovascular Medicine
